{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:26:25Z","timestamp":1794327985316,"version":"4.9.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52003097"],"award-info":[{"award-number":["52003097"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["CYJ20220530160603007"],"award-info":[{"award-number":["CYJ20220530160603007"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017610","name":"Shenzhen Science and Technology Innovation Program","doi-asserted-by":"publisher","award":["GJHZ20240218114707015"],"award-info":[{"award-number":["GJHZ20240218114707015"]}],"id":[{"id":"10.13039\/501100017610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003397","name":"Huazhong University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biomaterials.2025.123677","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T06:35:51Z","timestamp":1756794951000},"page":"123677","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["ROS-responsive resiquimod prodrug nanoparticles for macrophage reprogramming and enhanced immune checkpoint inhibitor therapy in bladder cancer"],"prefix":"10.1016","volume":"326","author":[{"given":"Rui","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haojie","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8418-143X","authenticated-orcid":false,"given":"Kun","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7503-3910","authenticated-orcid":false,"given":"Yijing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jintao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biomaterials.2025.123677_bib1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41571-023-00744-3","article-title":"A. Global trends in the Epidemiology of bladder cancer: challenges for Public Health and clinical Practice","volume":"20","author":"van Hoogstraten","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123677_bib2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.annonc.2021.11.012","article-title":"Bladder cancer: Esmo clinical Practice Guideline for Diagnosis, treatment and Follow-Up","volume":"33","author":"Powles","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123677_bib3","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1158\/2326-6066.CIR-19-0826","article-title":"CD40 agonist Restores the antitumor efficacy of anti-PD1 therapy in muscle-invasive bladder cancer in an IFN I\/II-mediated manner","volume":"8","author":"Leblond","year":"2020","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biomaterials.2025.123677_bib4","doi-asserted-by":"crossref","first-page":"8240","DOI":"10.1038\/s41467-024-52607-9","article-title":"Full-course NIR-II imaging-Navigated Fractionated Photodynamic therapy of bladder tumours with X-ray-activated Nanotransducers","volume":"15","author":"He","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123677_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41571-023-00826-2","article-title":"Progress in systemic therapy for advanced-stage Urothelial Carcinoma","volume":"21","author":"Nadal","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biomaterials.2025.123677_bib6","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41591-019-0628-7","article-title":"Clinical efficacy and Biomarker analysis of neoadjuvant Atezolizumab in Operable Urothelial Carcinoma in the Abacus trial","volume":"25","author":"Powles","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.biomaterials.2025.123677_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/CU9.0000000000000263","article-title":"Immune checkpoint inhibitor therapy as a neoadjuvant treatment for muscle-invasive bladder Carcinoma: a Narrative review","volume":"19","author":"Ding","year":"2025","journal-title":"Curr. Urol."},{"key":"10.1016\/j.biomaterials.2025.123677_bib8","article-title":"Fe\/Al-LDH Nanomedicine for antitumor Ferroptosis-immunotherapy by immunosuppression reversal","volume":"24","author":"Fang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib9","article-title":"Construction of Biomimetic Hybrid Nanovesicles based on M1 macrophage-derived Exosomes for therapy of cancer","volume":"26","author":"Li","year":"2025","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.biomaterials.2025.123677_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk7955","article-title":"Surgical tumor-derived Nanoplatform targets tumor-associated macrophage for Personalized Postsurgical cancer immunotherapy","volume":"10","author":"Qiao","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2025.123677_bib11","doi-asserted-by":"crossref","first-page":"8586","DOI":"10.1038\/s41467-024-53010-0","article-title":"Polymeric Nanocarrier via Metabolism regulation Mediates Immunogenic cell death with Spatiotemporal Orchestration for cancer immunotherapy","volume":"15","author":"Guo","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123677_bib12","article-title":"Synergizing CXCL9 with BRD4-PROTAC using Nanochaperone Boosts robust T cell-dependent antitumor immune responses for cancer immunotherapy","volume":"24","author":"Chen","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib13","doi-asserted-by":"crossref","first-page":"5653","DOI":"10.1038\/s41467-023-41438-9","article-title":"Cell Microparticles loaded with tumor Antigen and resiquimod reprogram tumor-associated macrophages and promote Stem-like CD8+ T cells to Boost anti-PD-1 therapy","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123677_bib14","doi-asserted-by":"crossref","first-page":"14424","DOI":"10.1021\/acsnano.2c12498","article-title":"Multifunctional Redox-responsive Nanoplatform with dual activation of macrophages and T cells for antitumor immunotherapy","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123677_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2024.100045","article-title":"Two-dimensional Nano-Biomaterials in regulating the tumor microenvironment for immunotherapy","volume":"3","author":"Xu","year":"2024","journal-title":"Nano TransMed"},{"key":"10.1016\/j.biomaterials.2025.123677_bib16","doi-asserted-by":"crossref","DOI":"10.1002\/anie.202417871","article-title":"Configuration-mediated efficient non-Radiative Transition for R848-Assisted Photothermal immunotherapy to inhibit tumor growth and metastasis by an in Situ tumor vaccine strategy","volume":"64","author":"Dai","year":"2025","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.biomaterials.2025.123677_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jconrel.2024.06.062","article-title":"Targeting tumor-associated macrophages with Mannosylated Nanotherapeutics delivering TLR7\/8 agonist enhances cancer immunotherapy","volume":"372","author":"Dang","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123677_bib18","doi-asserted-by":"crossref","first-page":"eadg2239","DOI":"10.1126\/sciadv.adg2239","article-title":"Engineering Kinetics of TLR7\/8 agonist release from Bottlebrush prodrugs Enables tumor-Focused immune stimulation","volume":"9","author":"Bhagchandani","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.biomaterials.2025.123677_bib19","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1039\/D2CS00647B","article-title":"Materials Engineering strategies for cancer vaccine adjuvant development","volume":"52","author":"Zhang","year":"2023","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.biomaterials.2025.123677_bib20","doi-asserted-by":"crossref","first-page":"4981","DOI":"10.1021\/acsnano.3c10862","article-title":"Twindrive Precise delivery system of Platelet-Neutrophil Hybrid Membrane Regulates macrophage combined with CD47 blocking for Postoperative immunotherapy","volume":"18","author":"Sheng","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123677_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102402","article-title":"ROS-responsive TLR7\/8 Nanoagonist and Ultrasound modulate dendritic cells Antigen Presentation","volume":"57","author":"Ren","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2025.123677_bib22","doi-asserted-by":"crossref","first-page":"12261","DOI":"10.1021\/acsnano.4c00844","article-title":"Light-triggered Nanozymes Remodel the tumor Hypoxic and immunosuppressive microenvironment for Ferroptosis-enhanced antitumor immunity","volume":"18","author":"Fan","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123677_bib23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41565-022-01296-w","article-title":"A Nanoadjuvant that Dynamically Coordinates innate immune Stimuli activation enhances cancer immunotherapy and reduces immune cell Exhaustion","volume":"18","author":"Jin","year":"2023","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123677_bib24","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-Agonist-Loaded nanoparticles promote the polarization of Tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2025.123677_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202311574","article-title":"Supramolecular Lipid nanoparticles based on host-guest recognition: a new generation delivery system of mRNA vaccines for cancer immunotherapy","volume":"36","author":"Qi","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2022.101651","article-title":"Nanoparticle-enabled concurrent modulation of phagocytosis and repolarization of macrophages for enhanced cancer immunotherapy","volume":"47","author":"Zhang","year":"2022","journal-title":"Nano Today"},{"key":"10.1016\/j.biomaterials.2025.123677_bib27","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.jconrel.2020.11.013","article-title":"Development of thermosensitive resiquimod-loaded liposomes for enhanced cancer immunotherapy","volume":"330","author":"Zhang","year":"2021","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123677_bib28","doi-asserted-by":"crossref","first-page":"15161","DOI":"10.1021\/acsnano.0c05392","article-title":"An intelligent biomimetic nanoplatform for holistic treatment of metastatic triple-negative breast cancer via Photothermal Ablation and immune remodeling","volume":"14","author":"Cheng","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123677_bib29","doi-asserted-by":"crossref","first-page":"8426","DOI":"10.7150\/thno.35434","article-title":"Development of adamantane-conjugated TLR7\/8 agonists for supramolecular delivery and cancer immunotherapy","volume":"9","author":"Rodell","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.biomaterials.2025.123677_bib30","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1080\/07853890.2022.2095664","article-title":"The role of toll-like receptors (TLRs) in pan-cancer","volume":"54","author":"Huang","year":"2022","journal-title":"Ann. Med."},{"key":"10.1016\/j.biomaterials.2025.123677_bib31","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.1021\/jacs.2c13218","article-title":"Highly sensitive imaging of tumor metastasis based on the targeting and polarization of M2-like macrophages","volume":"145","author":"Yuan","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biomaterials.2025.123677_bib32","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202200389","article-title":"Hybrid-membrane-decorated prussian blue for effective cancer immunotherapy via tumor-associated macrophages polarization and hypoxia Relief","volume":"34","author":"Hou","year":"2022","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/s41467-020-20723-x","article-title":"Boosting anti-PD-1 therapy with Metformin-loaded macrophage-derived microparticles","volume":"12","author":"Wei","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123677_bib34","article-title":"Dual-targeting to cancer cells and M2 macrophages via biomimetic delivery of Mannosylated Albumin nanoparticles for drug-resistant cancer therapy","volume":"30","author":"Zhao","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jconrel.2019.06.003","article-title":"Formulation and preclinical evaluation of a toll-like receptor 7\/8 agonist as an anti-tumoral immunomodulator","volume":"306","author":"Lu","year":"2019","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.biomaterials.2025.123677_bib36","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/cac2.12546","article-title":"Converting \"cold\" to \"hot\": epigenetics strategies to improve immune therapy effect by regulating tumor-associated immune suppressive cells","volume":"44","author":"Tang","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.biomaterials.2025.123677_bib37","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ccell.2023.02.016","article-title":"The evolving tumor microenvironment from cancer initiation to metastatic outgrowth","volume":"41","author":"de Visser","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biomaterials.2025.123677_bib38","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/s41551-021-00799-6","article-title":"Elimination of acquired resistance to PD-1 blockade via the concurrent depletion of tumour cells and immunosuppressive cells","volume":"5","author":"Xue","year":"2021","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.biomaterials.2025.123677_bib39","article-title":"Azide-masked resiquimod activated by hypoxia for selective tumor therapy","volume":"35","author":"Sun","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib40","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.biomaterials.2025.123677_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202211332","article-title":"Reprogramming hypoxic tumor-associated macrophages by nanoglycoclusters for boosted cancer immunotherapy","volume":"35","author":"Zhao","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib42","article-title":"Virulence-free reconstituted synthetic nanopathogen Empowered by Timely-activating TLR agonist promotes heterologous cancer immunotherapy with depletion of tumor-specific Treg cells","volume":"35","author":"Lee","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib43","doi-asserted-by":"crossref","first-page":"217486","DOI":"10.1016\/j.canlet.2025.217486","article-title":"Tumor-derived extracellular vesicle PD-1 promotes tumor immune evasion via disruption of peripheral T cell homeostasis","volume":"612","author":"Wang","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.biomaterials.2025.123677_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202370152","article-title":"Cuproptosis induced by ROS responsive nanoparticles with elesclomol and copper combined with \u03b1PD-L1 for enhanced cancer immunotherapy","volume":"35","author":"Guo","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib45","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41565-022-01098-0","article-title":"A nanovaccine for Antigen Self-Presentation and immunosuppression reversal as a Personalized cancer immunotherapy strategy","volume":"17","author":"Liu","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biomaterials.2025.123677_bib46","doi-asserted-by":"crossref","first-page":"5392","DOI":"10.1021\/acsnano.4c13463","article-title":"Rationally Engineered Bispecific Nanoimmunoblocker Restores anticancer immunity via dual immune checkpoint blockade","volume":"19","author":"Guan","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.biomaterials.2025.123677_bib47","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/s41568-024-00706-6","article-title":"Cancer organoids 2.0: Modelling the Complexity of the Tumour immune microenvironment","volume":"24","author":"Polak","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biomaterials.2025.123677_bib48","article-title":"Bioprinted organoids Platform with tumor Vasculature for Implementing Precision Personalized Medicine targeted towards Gastric cancer","volume":"34","author":"Kim","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.biomaterials.2025.123677_bib49","doi-asserted-by":"crossref","first-page":"6779","DOI":"10.1038\/s41467-023-42502-0","article-title":"Organoids Transplantation Attenuates Intestinal Ischemia\/Reperfusion injury in mice through L-Malic acid-mediated M2 macrophage polarization","volume":"14","author":"Zhang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biomaterials.2025.123677_bib50","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41563-021-01057-5","article-title":"Next-generation cancer organoids","volume":"21","author":"LeSavage","year":"2022","journal-title":"Nat. Mater."}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225005964?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961225005964?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T08:48:50Z","timestamp":1780303730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961225005964"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":50,"alternative-id":["S0142961225005964"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123677","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ROS-responsive resiquimod prodrug nanoparticles for macrophage reprogramming and enhanced immune checkpoint inhibitor therapy in bladder cancer","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2025.123677","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"123677"}}